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Abstract
The IL-2 receptor (礼-2R) Y chain, so-Called common γ (Yc) chain, which is shared with
multiple cytokine receptors, plays important rolesinthe immune system. We here
assessedthe immunosuppressive abihtyof mAb specificforthe Yc chainininduction of
1
CTLsandallograft rejecdonincombinationwithmAbs specific forthe αand β chains
of IL2R. CB〟N (Hl2k)mice wereinjected intraperitoneal1y withauogeneic
splenocytesfrom BALB/C (H-2d)mice,andthen administered withcombinations of
anti-IL-2Rα,anti-IL-2Rβ andanti-yc tnAbs or a control mAb. Addition ofanti-†c mAb
together withanti-I.-2Rαandanti｣112Rβ mAbsinddeea a complete inhibition of CTL
response･ The numbersand populations of CDl+cD8-and CD4ーCD8'T cens were not
significandy affected by admhistration of the threeanti-IL-2R mAbs, whereas NK cens
were completely depletedinspleens of mice treated withtheanti-a-2R mAbs･
Furthermore, skinallograftsurvivalwasalso significandy prolonged by administradon
of the three　anti-A-2R mAbs. These results suggestthatthe　anti-†c mAb　in
combination withanti-Ⅱ′2Rαandanti-礼-2Rβ TnAbs is capable of suppressing
induction of Cnsand NK cells, resulting ln Prolongation of skin anograftsurvival.
2
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Introduction
ILl2 is a T cell cytokine仇atinduces growth, differentiation,and activation of various
types of hematopoietic cells such as T, B, NK cellsand monocyte/macrophages via
interaction with 礼-2 receptors on their surfaces (1). The IL-2R consists of three
1
distinct subunits,the α (ml2Rα), β (IL-2Rβ)and † (A.-2Ry) chains,and IL-2Rβand
nl2Ry are essential for formation offunctionalhigh-andintemediate-affinityreceptors
(2). IL-2Ry, so-cauedthe common y (yc) chain, is shared as a common subunitamong
receptors for at least IL-2, 礼-4, ILl7, 礼-9, and 礼-15 (3)･ The †c chain is expressed
on almostall of the hematopoietic cell populations inT伽manand mouse (4, 5),and
mutations of the yc gene cause humanX-linked severe combined irrmunodeficiency
(XSCID) characterized by profound depression of Tand NK cell development (6, 7)･
Inmice deficient of the yc gene, development of mature Tand B ceus is profoundly
suppressedand NK ceus are absentinperipherallymphoid 也ssues (8-10)･ Recent
reports suggestthat signals throughthe Yc chain contribute to prevention of T ceu
anergyinduced by defect of costimulationthroughinteraction between CD28and B7
(1 I),and regulate activated T cell apoptosis (12). Moreover,the yc chainisinvolvedin
not onlythymocyte development butalso maintenanceand expansion of peripheralT
cells (13). Allthe cellularresponses throughthe yc chainarethought to be related tothe
imune system.
In organtransplantation, T ceusinrecIPlentS are activated by donor auoanhgens
to become Cn･Sand helper T cells producing a variety of cytokinesincluding IL-2
( 14),and the activated T cells expressthe inducible IL-2Rα together with m12Rβ and Yc
chains to be responsive to nl2 for proliferationandfunctionalactivation (1, 3).
Therefore, cytokine-secreting helper T cells and cytokine-responsive CTLs　are
prerequisites fortheallograftrejection (15)A In addition to auoantigen-specific CTLs,
NK ceusalso contribute to graft destruction (16). Not only CTLs butalso NK cells are
known to be responsive to n･-2 for proliferationandfunctionalactivation (17-18),
3
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suggestlngthat suppression of IL-2 function resultsinsuccessful transplantation･
indeed, so far,anti-IL-2Rαandanti-臥-2Rβ mAbs have been used as effective
immunosuppressantsinanimalexperiments (19-23)and c血icalstudies (24, 25),
althoughthese agents could not achievethe complete inl1ibition of graft rejection. We
1
have estabhshed monoclonalantibodies (mAbs) specificforthe mouse yc chairl, One Of
which, TUGm2, is able to block cell growth signaltransduction mediated by IL-2, IL-
4, IL-7, a-9and n115 (26-29)･ Using TUGm2, we successively achieved a complete
inhibition ofinvivo CTLinduction and a significant suppression of skinallograft
-,号
rejectioninmice.
4
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Methods
Mice
Six to seven week old CBA伽(H-2k), BALB/C (H-2d),and C57BIJ6 (H-2b) male
mice, which were purchased from Japan SLC Inc･, were used･
Monoclonal antibodies
The mAbs used are PC615.3 (anti-mouse 礼-2Rα, rat-IgGl ) obtained fromAmeric'an
Type Culture Conection, TUm122 (anti一mouse IL-2Rβ, rat-IgG2b) (30), TUGm2
(anti-mouse Yc, rat-IgG2b ) (26),and REY7 (anti-HでLV-I gp46, rat-IgG2b) (31).
¶leSe mAbs were purified withprotein-A column (AmpureW,Amersham). S4B6, a
mAb specific for mouse m12, was obtained frbmAmericanTissue Type Culture
Couection,and purified from culture supematants by protein-G Sepharose 4 Fast Flow
(Pbamacia Biotech ).
Mixed lymphocyte reaction
For mixed lymphocyte cultures, responder cens were prepared from spleens of mice by
removing erythrocytes upon treatment with TriS-NH.Cl･ 4x 105 responder spleen cells
were coICultured for 5 days with2×105 sthulator cens irradiated with3000 radin96-
well round-bottomedmicrotiter plates contamlng RPMI 1640 medium supplemented
with10% horse serum, amibiodcs, 2 mMLglutanhe, 25 mM HEPES, 0. 1 InM non-
essemialamino acidsand 50 LLM 2-ME･ The weusintriplicate were pulsed withl LLCi
of l3H]thymidineand radioac也vitiesinCorporatedinto cells were quandtated on a liquid
scintillation c ounter.
CTL induction and cytotoxicity assay
5
K･ Yasuda etal･　6
P8 15 (H-2d), a mastcytoma cellline derived from DBjV2J strainofmice, ELl4 (H-2b),
a T lymphoma cell he derived from C57BU6N strain,and B16 (H-2b), a melanoma
cell line derived from C57BU6 strain, were used as target ceusin51cr release CTL
assays as described previously (32)･ To induce CTLs, recipientmice were
1
intraperitoneany immunizedwith50×106 irradiated anogeneic splenocytes, andthen
intraperitoneaLy administered with anti-Ⅰし2R mAbs or a control mAb on day 0, 2,and
4･ On day 5, spleens were removedand the splenocytes were used as effTector cells in
51cr release assays･Altematively'the splenocytes were incubated withirradiated
-･せ
stimulator ceusinvitro for 5 days,andthen used as effector cellsin51cr release assays･
Target ceus (2xlO6) were labeled with0. I mCi Na251cro. (Amersham) at 3rC for 1 h
inRPMI 1640 medium containing lO% FCS,and washed threetimes with RPMI 1640
medium. 51cr-labeled target cells (5× 104) were added to seriald血tions of effector ceus
ina totalvolume of 200 plin96-weu round-bottomedmicroplates, centrifuged to
estabhsh ceu-cen contact･andincubated･ After 4 hincubation, the plates were
centrifugedandthe supernatants were haⅣested･ Radioactivities of the supematants
were countedina gamma counter･ Spontaneous release was lessthan10% of the
maximum release･ Results were expressed as follows･
% specific lysis =
Releaseintest - Spontaneous release
--------一一---I--- X 1 00
Maximum release - Spontaneous release
Tail skin grafting
Skingr姐ing was performed on anesthetized recipients as described by Bauey with
some modifications (33, 34)･ Briefly, a piece of donor tail skinabout 0.5 cm2and most
of the demis were removed witha scalpel,and transferred ontothe side of the recIPlent
tai1from which an equivalent area of skinhad been removed. Grafts werevisual1y
6
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monitored daily･ A graft was scored as rejected when 50% of the area of the graft had
undergone necrotic degeneration.
FIow cytometry
1
Immunofluorescence now cytomehicanalyses were performed as described elsewhere
(5)I Monoclonalantibodies used fortheflow cytometric analyses were FITC-
conjugated anti-CD4 (H 129･ 19) and PE-coupledanti-CD8a (53-6.7) purchased from
GIBCO BRL,and PE-coupledanti-NKl. I (PK136), FITC-Conjugatedanti-mouse H-
2b (KH95), PE-coupled anti一mouse H-2d (34-2-12 ), Fifc-Conjugatedanti-CD3e (145-
2Cl 1),and FITC-Conjugatedanti-αβTCR (H57-597) purchased from PharMhgen.
Ceus (lxlO6) wereincubatedwith 20 LLl of blocking reagents (culture supematant
containing 2･4G2,and-FcyRⅡ mAb,in50% normalrat serum 【Cedarlane]and 0.02%
NaN3)andallowed to stand on ice for 30min. They were then stained withthe mAbs
on ice for 30min, andanalyzed with aflow cytometer (FACScan, Becton Dicknson
Immunocytometry Systems) a氏er washing.
Statistical analysis
The statistical significance of the meansurvivalhe (MST) for skingraft was assessed
bythe Mann-W加tney U test･ The sigmificance of the other data was determined by
Student's i-test.
7
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Results
Inhibition of mixed lymphocyte reaction by administration of anti･ILl2R
mAbs
Effects ofanti-IL-2R mAbs on immune responses were first aSSeSSed in anospecific
I
mied lymphocyte reaction (MLR)invitro. Responderand stimulator cells were
splenocytes from C57BIJ6 (H12b)miceand BAIB/C (H-2d)mice, respectively.
Addition of a finalconcentration of 5 LLg/ml ofanti-A-2Rα rnAb, PC615.3into the
mked lymphocyte culture induced a 55% decreaseinPH】thymidine uptake as
compared withthat of the control mAb, REY-7 (Fig.- ･1チ.Anti-Ⅱ′2 mAb, S4B6also
inhibitedthe MLR equany weu toanti一m-2Rα mAb (Fig. 1), In contrast, eitheranti-
m-2Rβ rnAb, TUm122 or anti-yc mAb, TUGm2 hardly suppressedthe MLR at the
same concentration asanti-a-2Rα mAb,although morethan10times higher
concentrations ofanti-IL-2Rβ andanti-yc mAbs induced obvious suppression of l3H】
thymidine uptakeinthe MLR (data not shown). Chthe other hand,the combination of
anti-IL2Rβandanti-Yc mAbs significantly blocked l3H】thymidine uptakeinthe MLR,
butthe blocking level did not exceedthat withanti-IL2Rα血Abalone (p<0.05) (Fig.
1). 60%and 57% reductionsinthe MLR were obtained withthe addition ofanti-m-
2Rβ or a血-yc mAb together withanti-臥-2Rα mAb (p<0.05), respectively. Moreover,
the combination ofthethree mAbsalso showed 60%inhibition of the MLR. These
results suggestthatandJLl2Rα mAb, PC615･ 3 is capable of suppresslng alloantigen-
specific MLR,andalthough anti一m-2Rβ hlAb, TUm122 andanti-γc mAb, TUGm2,
themselves, have litde suppressive effect onthe MLR,they shghtly enhancethe
suppressive effect ofanti一m-2Rα mAb.
Effects of ants-IL･2R mAbs on T and NK cell populations in vivo
Prior to examination ofinvivo effects of the and一m12R mAbs on immune responses,
We asked whe血erinvivo lymphocyte subsetsare changed by administration of the
8
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mAbs･ CBA伽(H-2k)mice wereintraperitoneal1y hnmunized withirradiated
splenocytes of BALB/C (H12d)mice, and administeredintraperitoneally witha finalof
300 lLg Ofanti-a-2R mAbs consisting of 100 pg each ofanti-IL-2Rα, anti-礼-2Rβand
antl-YC mAbs, or 300リ.g Of a control mAb, REY-7, on day 0, 2and 4 after
1
irrmunization･ Their splenocytes were subjected to flow cytomeb･ic analyses. Authe
micethat had receivedthe combination of the threeanti-ml2R mAbs or REY-7, were
weu, withno sign of pnoerection, diarrhea or hypomotilityduringtheir treatment with
the mAbs･ Numbers of whole splenocytes were shghtly higher inmice treated with
REY-7 control mAb as compared withmice untreated-arid treated withthe combination
ofthethreeanti-臥-2R mAbs (data not shown). In spleen, CD4+cD81 and CD4~CD8+ T
cells wereincreasedinthemice treated withREY-7 mAb as compared withthemice
untreatedand treated withthe combination of the three mAbs (CD4+cD8~ : 29.4±1.7%
vs 26･7±3･8%, p<0･005, CD4lCD8': 18･7±1･9% vs 16･7±1.5%, p<0.05)昨ig. 2).
NKl I 1+TCRαβ~ NK cells were comp.letely depletedinspleens ofthemice treated with
thethreeanti一m-2R mAbs, butNKl･ 1+ TCRαβ+ T cens were unaffected (Fig. 2). On
the other hand･ T cell subpopulationsinthymus were notalteredanongal1the groups
of mice (data not shown)･ A血ost dl of the censinspleenand thymus were stained by
anti一mouse H12kantibody'confirrning thatallogeneic stimulator cells were elimhated in
vivo (data not shown). These resultsindicatethatinvivo admhistration of REY_7
control mAb resultsina shghtincrease of mature T cell subsets, whereas administradon
ofthethree anti-nl2R mAbs does not lead to such increase.
Effects of anti･ILl2R mAbs on induction ofalIospecific CTLs in vivo
Sincethe addition ofanti-礼-2Rβand anti-yc mAbsinduced a sight enhancement of
MLR suppression by anti-臥-2Rα mAb, we examined effTects of combinations ofand-
n･-2R mAbs oninduction of anoantigen-specific CTLsinvivo･ CBA伽(H-2k) recipient
9
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mice wereintraperitoneally immunized withirradiated splenocytes of BAIB/C (H-2d)
donormice,and administered either REY-7 control mAb or combinations of the three
anti-IL-2R mAbs intraperitoneally on day 0, 2and 4 after immunization. CTL
responses to donoralloanhgen were measured 5 days after immunization by a 51cr-
1
release assaywith P815 (H-2d) target cells･ There was no statistically sigmificant
difference in CTL responses between themice treated with300 LLg each of REY-7
Control mAbandtheanti-IL-2Rα mAb, PC615･3 (Fig･ 3A), suggestingthat 300 LIE Of
anti-IL-2Rα mAb hardly providesaninhibitory effect on auoantlgen-specific CTL
inducdoninvivo･ In contrast,the combination of 150- pgeach ofanti-IL2Rαandanti-
IL-2Rβ mAbs significandyinhibited CTLinduction as compared withREY-7 Control
mAbalone oranti-礼-2Rα mAbalone orthe combination of 150帽eaCh ofanti-A-2Rα
andanti-yc mAbs (Fig･ 3A)･ Moreover, administration of 100 LLg Ofanti-yc mAb
together with100 LLg each ofanti-Ⅱ-2Rαand anti-Ⅱ′2RP mAbs resultedinalmost
complete suppression of CTLinduction (Fig･ 3A)･ Administration of 300 pg of a血-IL-
2Rβ mAb oranti-yc mAb, or a totalof300 pg mAbs containing 150 pg each of a血一m-
2Rβandanti-Yc mAbs showed litde suppressive effect on CTLinduction (data not
shown)･ Usingthe reciprocalanogeneic combinadon of recipient BAL玉/C (H-2d)mice
and donor C57BU6 (H-2b)mice, effects ofanti-IL2R mAbs on CTLinduction was
also examined. The combined admistration bfthe three anti-Ⅱ′2R mAbsinduced the
most dramadc suppression of CTLinduction,and a significant suppression of CTL
induction wasinduced bythe combination of anti一m-2Rαand anti-IL-2Rβ mAbs, but
anti-nl2Rα mAbalone or its combination with ant1-YC mAb showed no effect on CTL
inducdon (Fig･ 3B). ne suppressive effect of combination ofthethree mAbs or anti_
臥-2Rαandanti-IL-2Rβ mAbs on CTLinduction was confirmed to be stadsticany
significant (Table 1)･ neallospecificities of CTLsinduced werealso con血med
reciprocally withP815 (H-2d)and B 16 (H-2b) (data not shown). These resultsindicate
that simultaneous administra血n ofallthe threeanti-Ⅱ√2R mAbs completelyinhibits
10
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induction ofalloantlgen SPeCific CTLs･ Since such CTLinduction was htde affected by
each mAbalone or the combination of the a山一IL-2Rβ and anti-Yc mAbs,and partially
inhibited by the combination of the anti-臥-2Rαandanti-IL-2Rβ mAbs, suggestingan
importance oftheanti-yc mAb, TUGm2, for complete suppression ofinvivo CTL
1
reSpOnSeS･
Surrvivalprolongation of MIIC-incompatible skin allografts inmice
treated with anti-IL･2R mAbs
Since skinallograftsareknown to be generally rejected血sterthanorganauografts, We
assessedtheinvivo immunosuppressive effect ofthethreeanti-nl2R mAbsinskin
auogTaftS･ Tan skingrafts of BALB/Cmice were trazISPlanted onto tans of recIPlent
CBAがmice on day 0, andthe recIPlentmice were adm血steredintraperitoneanywith a
totalof 300 pg of rr止bsinthe stipulated combinations ofanti-IL-2Rα,anti-IL-2Rβ,
anti-yc and REY-7 control mAbs, on day 0, 2, 4, 6and 8 after transplantation･ The
recIPlentmice treated withanti-ml2Rα mAb or REY-7 control mAb showed 8･ 6 days
or 6･4 days of meansurvivaltimes (MSTs) of skinanografts, whilethe combination of
anti-IL-2Rtxandanti-礼-2Rβ mAbs prolongedallograft survivalup to ll.4 days of
MST (Fig･ 4)･ Furthermore,the combination ofthethreeanti一m-2R IIIAbs,anti-IL-
2Rα,anti-IL-2Rβandanti-yc mAbs,induced bore significant prolongation of the skin
graft survivalup to 22･2 days of MST･ These results fairly correlated withthose of
CTL induction.
ll
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Discussion
ne immunosuppressive effTects of anti一m-2Rαandanti-礼-2Rβ mAbs have been
previously reportedintransplantationsinhumanSandmice (20-25)･ Sincethefully
functionalm-2 receptorincludesthe Yc chain asanindispensable receptor subunit in
1
addition to IL-2R(x and ml2RP, coupledwiththe factthat it is sharedwithreceptors for
other cytokines such as IL-4, IL-7, m19and 臥-15 (3), we hypothesizedthat antトγc
mAb contributes to culmination ofinhibitory effects of anti-礼-2Rαandanti-礼-2Rβ
mAbs on 礼-2 function･and to suppression offunctions of the other cytokines sharing
the yc chain, which would be beneficialto immune suppression. We here demonstrated
thatanti-yc mAb c0-Operates withanti-礼-2Rαandanti-IL2Rβ mAbsinimmune
suppression of in vivoalloantigen-specific CTL responsesand skin allografts･
We f:lrSt COnfirmedthe suppressive activity ofanti-礼-2Rα mAb for MLR
representlng PrOliferadon of T cellsinresponse to anoandgen in vitro･Althoughthe
combination betweenanti-臥-2Rα mAbandanti一m-2Rβ mAb oranti-yc mAb,and
combination ofthethreeanti-臥-2R mAbs showed shghdy enhanced levels of inhibition
of MLRincomparison withanti-ILl2Rα mAbalone, eitheranti-ml2Rβ oranti-Yc rnAb
alone had no effect on MLR･ These results are consistent withthe previous
observationsthatthe IL12R complex consisting of the 臥-2Rα, Ⅱ′2Rβand †c but not
the complex consisting of the H･-2Rβand †c isfunctionalinthe murine system unlike
the humansystem,andtherebyanti-礼-2Rα mAb completely blocks IL-2-mediated cell
growth, while each ofanti-礼-2Rβ oranti-Yc mAb reduces a-2 bin'ding affinity of the
high-affhityIL-2R but is unable to blockthe T cen growthmediated by 礼-2 (26, 30,
35)･ Sincethe IL-2Rα chain is not shared with other cytokine receptors apart from IL-
2R,the significantinhibition of MLR bythe anti-臥-2Rα mAbalone suggeststhat 礼-2
is a major humoralfactor mediating MLRinvitro.
Notwithstandingthe significant suppressive activity ofantiJL-2Rα mAb onin
vitro MLR,anti-ml2Rα mAbinduced a mhimalsuppression forinvivo CTLinduction
12
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similar toanti-ml2Rβandanti-Yc mAbs, whereas the combination ofantLm-2Rα and
anti-礼-2Rβ mAbs but notthe combination of anti-礼-2Rαandanti-†c mAbs showed
significantinhibition of CTLinduction. Furthermore,the combination of the threeand一
礼-2R mAbsinducedalmost completeinhibition of Cn responseinthe combination
I
between recIPlent CB〟Nand donor BALB/Cmice･ In considering why anti-Ⅱ′2Rα
mAbalone has no suppressive effect oninvivo CTL response,although itinduces a
powerful suppressive effect oninvitro MLR, one could attribute this disparityto a
differenceintheinvivoandinvitro environmentalcircumstances, affecting dilution,
inactivation　and possibly degradation of a血-Ⅱ′2R蝕　mAb. We　also observed
significant suppression of skinallograft by a combined admimistradon of a山一Ⅱ√2Rα
andanti-Ⅱ′2Rβ mAbs orthethree and-a-2R mAbs, butanti-Ⅱ′2Rα InAbalonelitde
induced suppression of skinauograft. However, administration ofanti-礼-2Rα mAb
alone was previously reported to be significantly effective for suppression of skin
anograftrejectionincertainstrains of mice but not generauy (23). These observations
taken together withour present results suggestthattheinvivo immunosuppressive
effect of and-IL-2Rα mAbalone may beinfluenced by irrmunogenetic basis of mouse
strainS･ These results flrSt SuggeStthe possibihtythatanti-ycandanti-IL-2Rβ mAbs
engendersthe significant suppressive activity ofanti-礼-2Rα mAb forinvivo IL2
funcdon which is critiCallyinvolved inin■vivo immune responses such as CTL
inductionand auograft reJection･ However, it has been reportedthat islet ceu anografts
canbe rejected eveninn-21deficientmice, suggesting the possible existence of a-2-
independent mechanismforallograftrejectiOn probablyincludinginduction of CTLand
other effector ceus such as NK cells (36). Hence, it isalSo possiblethatanti-ycand
an也一m-2Rβ mAbs contribute to suppression of funcdons of other cytokines sharing the
ycand a-2RP chains as receptor subunits, which would beinvolvedininvivo immune
responsesI In fact, ILl4, 臥-7, 礼-9and 礼-15, au of whichinteract withthe γc chain,
areknown to beinvolvedininvivo developmentand ac止vation ofT and NK ceus (37-
13
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41);the aJlti-YC mAb, TUGm2, used here isknown to significandyinhibitinvitro
functions of 臥-4, 臥-7, IL-9and IL-15 (26-29),andinvivo admhistration of anti-IL-
2Rβ mAb isalsoknown to deplete NK ceus (42). nerefore, NK ceus as wen as T
ceus are target ceus of anti-臥-2Rβandanti-Yc mAbs for suppression of induction of
I
CTLandallograft rejection.
The present study con血med血e entire depletion of NK1. 1十TCR岬NK cells
upon treatment of mice withtheantiJL-2R mAbs,although T cell subpopulations such
as CD4-CD8+and CD4+CD8- T cens were little affTected byinvivo admistradon of
anti-IL-2R mAbs･ Administration of REY7 Control mAb血duced a slightincrease of the
T cell subpopulations, which may be due to amigenic stimulation with REY7 mAb (rat
IgG), whileantigenic stimulation withanti-a-2R mAbs (rat IgG) mayalso be
suppressed bythernselvesI The deletion of NK cells isthought to be derived from
functionalblocking of IL-2 and a-15 byanti-IL-2RPandanti-yc mAbs, because both
the 礼-2Rβand Yc chainSare receptor subunits for IL-2and 礼-15 (29),and not only
IL-2 butalso 臥-15 areknown to beinvolvedindevelopmentand activation of NK
cells (44-46)･ Authese observations supportthe observationthat anti-†C mAb in
combination withanti-ml2Rαand anti-臥-2RP mAbs is more effective fTorinvivo
immunosuppressionthananti-礼-2Rα mAbalone or any other combinadon of the anti-
m-2R InAbs.
14
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Abbreyiations
IL-2R, IL-2 receptor
礼-2Rα, 臥-2R α chain
IL-2Rβ, ml2R β chain
I
Yc, 臥-2R † chain / common Y chain
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Legends to Figures
Figure 1: Effects of anti･IL-2R mAbs onmixed lymphocyte reaction･
Responder spleen ceus of C57BIJ6mice were co-cultured with irradiated stimulator
spleen ceus of BALB/Cmice for 5 daysin961Well roundbottomedmicrotiter plates in
1
the presence of purified mAbs: (a) 15 LLg Of REY7 Control mAb, (b) 5帽Ofanti-IL-
2Rα rrlAb (PC 615.3)and 10 pg REY-7, (C) 5 pg ofanti｣し2Rβ mAb (TUm122)and
long ofREY-7, (d) 5帽Ofanti-yc mAb (TUG血2)and 10 LLg OfREY-7, (e) 5 pg of
anti-礼-2Rα mAb, 5 p･g ofanti-臥-2Rβ mAband 5 LLg Of REY7, (f).5 LLg Ofanti-IL-2Rα
mAb, 5 pg ofanti-Yc mAband 5 pg ofREY7, (g) 5腔Ofanti-礼-2Rβ mAb, 5 pg of
anti-Yc mAb and 5 pg of REY7, (h) 5 pg ofanti-A-2Rα mAb, 5帽Ofanti-Ⅱ√2Rβ
mAband 5一g ofanti-Yc mAb,and (i) 5 p･g ofanti-IL-2 rnAb (S4B6)and 10 llg Of
REY-7･ ne reponder cdls werealso stimulated withsyngeneic C57Bu6 spleen ceus
o). Duringthe last 18 hr of culture, 1.0 mCi of l3H]thymidine was pulsed･
Radioactivities incorporatedintothe cens were counted･ Results are represented as
meanvaluesand standard deviations in triplicate assays･ b, e, f, g, hand i are p < 0･05･
Figure 2: Immunofluorescence analysis for T and NK cell poplllations in
spleens of mice treatedwith anti･ILl2R mAbs･
C57BL/6 (H-2b)mice were administered with purified mAbs: no mAb (untreated), 300
pg of REY-7 (Control mAb),and 100 LLg each ofanti-IL-2Rα mAb,anti-_IL-2Rβ mAb
andanti-yc mAb (combination), on day 0, 2, and 4･ On day 5, splenocytes ofthemice
were subjected to flow cytomebicanalyses;they were incubated with20 ul of blocking
reagents (culture supematant containinganti-FcyRII mAb (2･4G2) in 50% normalrat
serum lCedarlane]and O･02% NaN3) on ice for 30min,then stained withanti-CD4
mAb (H129.19),anti-CD8a mAb (53-6.7)andanti-NKl･l mAb (PK136) on ice for 30
min,andanalyzed withaflow cytometer (FACScan) after washing･ Thepercentage of
21
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positively stained cells is indicated bythe numberineach quadrant･ * : p < 0･005, ** :
p<0.05
Figure 3: Effects of anti-IL･2R mAbs on in vivo CTL induction.
cB〟N (H-2k)mice were intraperitoneally immumized withsplenocytes of BALB/C (H-
2d)mice (A), or vice verse (B). Themice werethen treated withmAbs: 300帽Of
REY7 Control mAb (○), 300 pg ofanti-IL-2Rα mAb (田), 150 LLg each ofanti-IL-2Rα
mAband a血- Yc mAb (△), 150 pg each ofantilLl2Rα mAbandanti-IL-2Rβ rnAb
･一や
(+ ),and 100 pg each ofanti-IL-2RαmAb, anti-ILl2Rβ mAbandanti-yc mAb (● ),
on day 0, 2and 4 after immunization. On day 5, spleens were removedand splenocytes
were used as effector ceusincytotoxicityassays withradiolabened target cells of P8 15
(H-2d) (A)and EL-4 (H-2b) p). Results were represented as meanValuesand standard
diviations in triplicates.
Figure　4: Effects of anti･IL-2R mAbs on MHC-incompatible skin
allograrts.
Tail skingrafts of BALB/C (H12d)mice were transplanted onto the tails of CBA桝田-
2k)mice. Recipientmice were admimisteredintraperitoneany withanti一m-2R mAbs on
day 0, 2, 4, 6and 8 after transplantation. Fivemice were administered with300 llg Of
REY7 Control mAb (○), fivemice were administered with300 LLg Ofanti-IL-2Rα
mAb, PC615.3 (● ), tenmice were administeredwith150 LLg each ofanti-IL12Rα
mAbandanti-IL-2Rβ mAb, TUm122 (A),and sixmice were administered with 100 LLg
each of anti一m-2Rα mAb,anti一m-2Rβ mAbandanti-†c mAb, TUGm2 (◆ ). Grafts
were visually momitored daily.
22
Table l : Effects of AntHL2R mAbs on in vivo AlIospecific CTL Induction
Allospecific CTL
Mice in vivo treatment Stimulator TargetE/r Ratio
200:1　　　　　100:1　　　　　　　50:1
CBAノN control
n=5　　　　　　α
α+γC
α+β
BALD/C 4°
BALB/c
B ALB/c
B ALB/C
α +β+γ c BALB/C
22=522iiif･_il13i';92 ,3] a:b 1125387g'66?87享i?lI.:.;24 ],: a:d
13.0±2.8
9.4±2 0
9.4±1.7
4.1±1.3
3.3±1.0
a
]
]a
]C
]a
BALB/c COntrOl
n=3　　　　　　α
α+γC
α十β
C57BU6　　　EL-4　　　　　　　59.6 ± 7.4
C57BU6　　　EL4
C5 7 BL/6　　.EL_4
C57 BU6　　　EL-4
α +β +γ c c57BU6　　EL-4
66.0±2.8
66･5- ]]
34･2±7･7 ] d
46･0±8･2] a
56.4±3.7
58.8±7.2
23.7±7.2
26.0±5.9　　　　17.2±3.7
36･5±9･2 ] a
44･0±0･6 ] a
45･1±7･01 b
15.4±5.4
1) CBA /N(H-2k) mice were intraperitoneally immunized with splenocytes of BALB/C(H-2d)mice, or vice verse･ THemice were then
treated with mAbs: 300iL g REY7(control), 300FL g PC615.3( a ), 150FL g each ofPC615･3 and TUm122 ( a +P), and lOOFL g each ofPC615･3,
TUm122 alld TUGm2( α + β + γ C ), on day 0, 2 and 4 a鮎r immunization. On day 5, spleens were removed and splenocytes were used as
effector cells in a 5 lcr release assay with radiolabelled P815(H-2d) and EL-4(H-2b) target cells･ Results were represented as mean values and
standard divisions in triplicates･ a:not slgnificantt, b: p≦0･005, C: p≦0･01, d:≦ 0･05
???????????? ??????
??
~____■
untreated Control mAbcombination
TCR αβ
? ? ?
200:1　100:1　　50:1200:1　　100:1　　　50:1
E/T ratio
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